Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Xu, Qin ^a   Liu, Xiuming ^a   Chen, Wantao ^a   Zhang, Zhiyuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; SHORT HAIRPIN RNA; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; SECRETASE;

ADENOID CYSTIC CARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; WESTERN BLOTTING; ANIMAL; CELL MOTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; NEOPLASM METASTASIS; RNA INTERFERENCE; RNA, MESSENGER;

EID: 78650263186     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-136     Document Type: Article

References (35)

1. Van der Wal JE, Becking AG, Snow GB, van der Waal I. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck 2002, 24:779-83. 10.1002/hed.10126, 12203804.
2. Ramer N, Wu H, Sabo E, Ramer Y, Emanuel P, Orta L, Burstein DE. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Cancer 2010, 116:77-83.
3. Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 2008, 8:929-41. 10.1038/nrc2459, 19005493.
4. Lu X, Lu D, Scully M, Kakkar V. ADAM proteins - therapeutic potential in cancer. Curr Cancer Drug Targets 2008, 8:720-32. 10.2174/156800908786733478, 19075595.
5. Wu K, Liao M, Liu B, Deng Z. ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients. Med Oncol
6. Zubel A, Flechtenmacher C, Edler L, Alonso A. Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix. Gynecol Oncol 2009, 114:332-6. 10.1016/j.ygyno.2009.05.005, 19473694.
7. McCulloch DR, Harvey M, Herington AC. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol Cell Endocrinol 2000, 167:11-21. 10.1016/S0303-7207(00)00305-1, 11000516.
8. Endres K, Fahrenholz F. Upregulation of the alpha-secretase ADAM10--risk or reason for hope?. FEBS J 2010, 277:1585-96. 10.1111/j.1742-4658.2010.07566.x, 20136654.
9. Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, Sako Y, Yanagida T, Miyasaka M. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J Biol Chem 2004, 279:4541-50. 10.1074/jbc.M307356200, 14623895.
10. Huang D, Chen W, Zhang Z, Zhang P, He R, Zhou X, Qiu W. Identification of genes with consistent expression alteration pattern in ACC-2 and ACC-M cells by cDNA array. Chin Med J (Engl) 2003, 116:448-52.
11. Hu K, Li SL, Gan YH, Wang CY, Yu GY. Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt. Oral Oncol 2009, 45:156-63. 10.1016/j.oraloncology.2008.04.009, 18620900.
12. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984, 54:1062-9. 10.1002/1097-0142(19840915)54:6<1062::AID-CNCR2820540622 >3.0.CO;2-E, 6088017.
13. Xu Q, Zhang Z, Zhang P, Chen W. Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinoma. BMC Cancer 2008, 8:159. 10.1186/1471-2407-8-159, 2427037, 18522733.
14. Wang-Tilz Y, Tilz C, Wang B, Tilz GP, Stefan H. Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy. Epilepsia 2006, 47:233-9. 10.1111/j.1528-1167.2006.00414.x, 16499746.
15. van Holten J, Smeets TJ, Blankert P, Tak PP. Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis. Ann Rheum Dis 2005, 64:1780-2. 10.1136/ard.2005.040477, 1755294, 15878901.
16. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296:550-3. 10.1126/science.1068999, 11910072.
17. Yu Y, Chen W, Zhang Y, Hamburger AW, Pan H, Zhang Z. Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer. Int J Cancer 2007, 120:1909-13. 10.1002/ijc.22541, 17266032.
18. Cuneo KC, Fu A, Osusky KL, Geng L. Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasis. Anticancer Drugs 2007, 18:349-55. 10.1097/CAD.0b013e328011fdab, 17264769.
19. Nakashima Y, Yano M, Kobayashi Y, Moriyama S, Sasaki H, Toyama T, Yamashita H, Fukai I, Iwase H, Yamakawa Y, et al. Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery. Gene Ther 2003, 10:123-30. 10.1038/sj.gt.3301856, 12571641.
20. Walser TC, Rifat S, Ma X, Kundu N, Ward C, Goloubeva O, Johnson MG, Medina JC, Collins TL, Fulton AM. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res 2006, 66:7701-7. 10.1158/0008-5472.CAN-06-0709, 16885372.
21. Lee SB, Schramme A, Doberstein K, Dummer R, Abdel-Bakky MS, Keller S, Altevogt P, Oh ST, Reichrath J, Oxmann D, et al. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J Invest Dermatol 2010, 130:763-73. 10.1038/jid.2009.335, 19865098.
22. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005, 168:633-42. 10.1083/jcb.200408051, 2171754, 15716380.
23. Makale M. Cellular mechanobiology and cancer metastasis. Birth Defects Res C Embryo Today 2007, 81:329-43. 10.1002/bdrc.20110, 18228263.
24. Anderegg U, Eichenberg T, Parthaune T, Haiduk C, Saalbach A, Milkova L, Ludwig A, Grosche J, Averbeck M, Gebhardt C, et al. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells. J Invest Dermatol 2009, 129:1471-82. 10.1038/jid.2008.323, 18971959.
25. Tian L, Wu X, Chi C, Han M, Xu T, Zhuang Y. ADAM10 is essential for proteolytic activation of Notch during thymocyte development. Int Immunol 2008, 20:1181-7. 10.1093/intimm/dxn076, 18635581.
26. Dyczynska E, Sun D, Yi H, Sehara-Fujisawa A, Blobel CP, Zolkiewska A. Proteolytic processing of delta-like 1 by ADAM proteases. J Biol Chem 2007, 282:436-44. 10.1074/jbc.M605451200, 2692894, 17107962.
27. Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW, Liu TY. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett 2007, 245:33-43. 10.1016/j.canlet.2005.10.019, 16309826.
28. Arima T, Enokida H, Kubo H, Kagara I, Matsuda R, Toki K, Nishimura H, Chiyomaru T, Tatarano S, Idesako T, et al. Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer. Cancer Sci 2007, 98:1720-6. 10.1111/j.1349-7006.2007.00601.x, 17727679.
29. Allinson TM, Parkin ET, Turner AJ, Hooper NM. ADAMs family members as amyloid precursor protein alpha-secretases. J Neurosci Res 2003, 74:342-52. 10.1002/jnr.10737, 14598310.
30. Jorissen E, Prox J, Bernreuther C, Weber S, Schwanbeck R, Serneels L, Snellinx A, Craessaerts K, Thathiah A, Tesseur I, et al. The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci 2010, 30:4833-44. 10.1523/JNEUROSCI.5221-09.2010, 20371803.
31. Jacobsen KT, Adlerz L, Multhaup G, Iverfeldt K. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases. J Biol Chem 2010, 285:10223-31. 10.1074/jbc.M109.038224, 20139073.
32. Fan X, Liu Y, Jiang J, Ma Z, Wu H, Liu T, Liu M, Li X, Tang H. miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) 2010, 42:318-24. 10.1093/abbs/gmq026, 20458444.
33. Venkataramani V, Rossner C, Iffland L, Schweyer S, Tamboli IY, Walter J, Wirths O, Bayer TA. Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J Biol Chem 2010, 285:10678-89. 10.1074/jbc.M109.057836, 20145244.
34. Zhao H, Zhu J, Cui K, Xu X, O'Brien M, Wong KK, Kesari S, Xia W, Wong ST. Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid beta protein. Cancer Cell Int 2009, 9:15. 10.1186/1475-2867-9-15, 2701410, 19480719.
35. Jin EJ, Choi YA, Sonn JK, Kang SS. Suppression of ADAM 10-induced Delta-1 shedding inhibits cell proliferation during the chondro-inhibitory action of TGF-beta3. Mol Cells 2007, 24:139-47.